These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 7607575)
1. Biotechnological and gene therapeutic strategies in cancer treatment. Wels W; Moritz D; Schmidt M; Jeschke M; Hynes NE; Groner B Gene; 1995 Jun; 159(1):73-80. PubMed ID: 7607575 [TBL] [Abstract][Full Text] [Related]
2. EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Wels W; Beerli R; Hellmann P; Schmidt M; Marte BM; Kornilova ES; Hekele A; Mendelsohn J; Groner B; Hynes NE Int J Cancer; 1995 Jan; 60(1):137-44. PubMed ID: 7814146 [TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha. Schmidt M; Wels W Br J Cancer; 1996 Sep; 74(6):853-62. PubMed ID: 8826849 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Wels W; Harwerth IM; Mueller M; Groner B; Hynes NE Cancer Res; 1992 Nov; 52(22):6310-7. PubMed ID: 1358432 [TBL] [Abstract][Full Text] [Related]
5. Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo. Azemar M; Schmidt M; Arlt F; Kennel P; Brandt B; Papadimitriou A; Groner B; Wels W Int J Cancer; 2000 Apr; 86(2):269-75. PubMed ID: 10738256 [TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2. Schmidt M; McWatters A; White RA; Groner B; Wels W; Fan Z; Bast RC Gynecol Oncol; 2001 Feb; 80(2):145-55. PubMed ID: 11161852 [TBL] [Abstract][Full Text] [Related]
7. A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor. Schmidt M; Hynes NE; Groner B; Wels W Int J Cancer; 1996 Feb; 65(4):538-46. PubMed ID: 8621240 [TBL] [Abstract][Full Text] [Related]
8. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice. Reiter Y; Wright AF; Tonge DW; Pastan I Int J Cancer; 1996 Jul; 67(1):113-23. PubMed ID: 8690511 [TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression. Altenschmidt U; Klundt E; Groner B J Immunol; 1997 Dec; 159(11):5509-15. PubMed ID: 9548491 [TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin. Altenschmidt U; Schmidt M; Groner B; Wels W Int J Cancer; 1997 Sep; 73(1):117-24. PubMed ID: 9334818 [TBL] [Abstract][Full Text] [Related]
11. Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice. Bruell D; Bruns CJ; Yezhelyev M; Huhn M; Müller J; Ischenko I; Fischer R; Finnern R; Jauch KW; Barth S Int J Mol Med; 2005 Feb; 15(2):305-13. PubMed ID: 15647848 [TBL] [Abstract][Full Text] [Related]
12. Chemosensitivity testing of oral cancer cells treated with a p185neu-specific agent. Werkmeister R; Fillies T; Brandt B; Groner B; Weis W; Joos U Eur J Oral Sci; 1999 Oct; 107(5):338-43. PubMed ID: 10515198 [TBL] [Abstract][Full Text] [Related]
13. Construction and in vitro evaluation of RFT5(scFv)-ETA', a new recombinant single-chain immunotoxin with specific cytotoxicity toward CD25+ Hodgkin-derived cell lines. Barth S; Huhn M; Wels W; Diehl V; Engert A Int J Mol Med; 1998 Jan; 1(1):249-56. PubMed ID: 9852227 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells. Moritz D; Wels W; Mattern J; Groner B Proc Natl Acad Sci U S A; 1994 May; 91(10):4318-22. PubMed ID: 7910405 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells. Wang L; Liu B; Schmidt M; Lu Y; Wels W; Fan Z Prostate; 2001 Apr; 47(1):21-8. PubMed ID: 11304726 [TBL] [Abstract][Full Text] [Related]
16. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. Reiter Y; Brinkmann U; Jung SH; Lee B; Kasprzyk PG; King CR; Pastan I J Biol Chem; 1994 Jul; 269(28):18327-31. PubMed ID: 7913461 [TBL] [Abstract][Full Text] [Related]
17. Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells. Maurer-Gebhard M; Schmidt M; Azemar M; Altenschmidt U; Stöcklin E; Wels W; Groner B Cancer Res; 1998 Jun; 58(12):2661-6. PubMed ID: 9635594 [TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Jeschke M; Wels W; Dengler W; Imber R; Stöcklin E; Groner B Int J Cancer; 1995 Mar; 60(5):730-9. PubMed ID: 7860149 [TBL] [Abstract][Full Text] [Related]
19. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors. Schmidt M; Maurer-Gebhard M; Groner B; Köhler G; Brochmann-Santos G; Wels W Oncogene; 1999 Mar; 18(9):1711-21. PubMed ID: 10208432 [TBL] [Abstract][Full Text] [Related]
20. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3. Benhar I; Pastan I J Biol Chem; 1995 Oct; 270(40):23373-80. PubMed ID: 7559495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]